HEADER VIRAL PROTEIN/HYDROLASE 15-OCT-23 8WRL TITLE XBB.1.5 RBD IN COMPLEX WITH ACE2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROCESSED ANGIOTENSIN-CONVERTING ENZYME 2; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: SPIKE PROTEIN S1; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: RBD DOMAIN; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE2, UNQ868/PRO1885; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 11 2; SOURCE 12 ORGANISM_COMMON: 2019-NCOV,SARS-COV-2; SOURCE 13 ORGANISM_TAXID: 2697049; SOURCE 14 STRAIN: OMICRON/XBB.1.5; SOURCE 15 GENE: S, 2; SOURCE 16 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 17 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, XBB.1.5, ACE2, RBD, VIRAL PROTEIN/HYDROLASE, VIRAL KEYWDS 2 PROTEIN-HYDROLASE COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR L.L.FENG,L.L.FENG REVDAT 2 17-APR-24 8WRL 1 COMPND SOURCE REMARK DBREF REVDAT 2 2 1 SEQADV SEQRES HELIX SHEET REVDAT 2 3 1 SSBOND LINK ATOM REVDAT 1 29-NOV-23 8WRL 0 JRNL AUTH L.L.FENG JRNL TITL XBB.1.5 RBD IN COMPLEX WITH ACE2 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.36 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.360 REMARK 3 NUMBER OF PARTICLES : 226753 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8WRL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 17-OCT-23. REMARK 100 THE DEPOSITION ID IS D_1300041910. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2; HUMAN ACE2; XBB.1.5 REMARK 245 RBD REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : FEI FALCON IV (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1800.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5200.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 300 REMARK 465 PRO B 301 REMARK 465 LEU B 302 REMARK 465 LEU B 303 REMARK 465 LEU B 304 REMARK 465 LEU B 305 REMARK 465 LEU B 306 REMARK 465 PRO B 307 REMARK 465 LEU B 308 REMARK 465 LEU B 309 REMARK 465 TRP B 310 REMARK 465 ALA B 311 REMARK 465 GLY B 312 REMARK 465 ALA B 313 REMARK 465 LEU B 314 REMARK 465 ALA B 315 REMARK 465 MET B 316 REMARK 465 ALA B 317 REMARK 465 ALA B 318 REMARK 465 ARG B 319 REMARK 465 VAL B 320 REMARK 465 GLN B 321 REMARK 465 PRO B 322 REMARK 465 THR B 323 REMARK 465 GLU B 324 REMARK 465 SER B 325 REMARK 465 ILE B 326 REMARK 465 VAL B 327 REMARK 465 ARG B 328 REMARK 465 PHE B 329 REMARK 465 PRO B 330 REMARK 465 ASN B 331 REMARK 465 ILE B 332 REMARK 465 THR B 333 REMARK 465 SER B 530 REMARK 465 THR B 531 REMARK 465 ASN B 532 REMARK 465 LEU B 533 REMARK 465 VAL B 534 REMARK 465 LYS B 535 REMARK 465 ASN B 536 REMARK 465 LYS B 537 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 136 -141.14 59.80 REMARK 500 CYS A 261 151.94 67.55 REMARK 500 ASP A 303 -132.34 36.50 REMARK 500 SER A 331 161.01 -46.44 REMARK 500 MET A 360 132.42 174.39 REMARK 500 LEU A 423 50.14 -92.43 REMARK 500 TRP A 473 -62.97 -103.29 REMARK 500 ILE A 484 -62.73 -103.26 REMARK 500 THR A 496 37.76 -69.54 REMARK 500 SER A 502 12.67 104.32 REMARK 500 PHE A 588 35.27 -87.10 REMARK 500 HIS B 339 -35.54 -130.28 REMARK 500 ALA B 352 66.87 -103.03 REMARK 500 PRO B 373 22.39 -79.22 REMARK 500 ASN B 388 50.56 -92.57 REMARK 500 ASP B 428 36.35 -98.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 169 0.29 SIDE CHAIN REMARK 500 ARG A 357 0.12 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-37779 RELATED DB: EMDB REMARK 900 XBB.1.5.10 RBD IN COMPLEX WITH ACE2 DBREF 8WRL A 19 612 UNP Q9BYF1 ACE2_HUMAN 19 612 DBREF 8WRL B 319 537 UNP P0DTC2 SPIKE_SARS2 319 537 SEQADV 8WRL MET B 300 UNP P0DTC2 INITIATING METHIONINE SEQADV 8WRL PRO B 301 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL LEU B 302 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL LEU B 303 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL LEU B 304 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL LEU B 305 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL LEU B 306 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL PRO B 307 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL LEU B 308 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL LEU B 309 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL TRP B 310 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL ALA B 311 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL GLY B 312 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL ALA B 313 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL LEU B 314 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL ALA B 315 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL MET B 316 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL ALA B 317 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL ALA B 318 UNP P0DTC2 EXPRESSION TAG SEQADV 8WRL HIS B 339 UNP P0DTC2 GLY 339 VARIANT SEQADV 8WRL THR B 346 UNP P0DTC2 ARG 346 VARIANT SEQADV 8WRL ILE B 368 UNP P0DTC2 LEU 368 VARIANT SEQADV 8WRL PHE B 371 UNP P0DTC2 SER 371 VARIANT SEQADV 8WRL PRO B 373 UNP P0DTC2 SER 373 VARIANT SEQADV 8WRL PHE B 375 UNP P0DTC2 SER 375 VARIANT SEQADV 8WRL ALA B 376 UNP P0DTC2 THR 376 VARIANT SEQADV 8WRL ASN B 405 UNP P0DTC2 ASP 405 VARIANT SEQADV 8WRL SER B 408 UNP P0DTC2 ARG 408 VARIANT SEQADV 8WRL ASN B 417 UNP P0DTC2 LYS 417 VARIANT SEQADV 8WRL LYS B 440 UNP P0DTC2 ASN 440 VARIANT SEQADV 8WRL PRO B 445 UNP P0DTC2 VAL 445 VARIANT SEQADV 8WRL SER B 446 UNP P0DTC2 GLY 446 VARIANT SEQADV 8WRL LYS B 460 UNP P0DTC2 ASN 460 VARIANT SEQADV 8WRL ASN B 477 UNP P0DTC2 SER 477 VARIANT SEQADV 8WRL LYS B 478 UNP P0DTC2 THR 478 VARIANT SEQADV 8WRL ALA B 484 UNP P0DTC2 GLU 484 VARIANT SEQADV 8WRL PRO B 486 UNP P0DTC2 PHE 486 VARIANT SEQADV 8WRL SER B 490 UNP P0DTC2 PHE 490 VARIANT SEQADV 8WRL ARG B 498 UNP P0DTC2 GLN 498 VARIANT SEQADV 8WRL TYR B 501 UNP P0DTC2 ASN 501 VARIANT SEQADV 8WRL HIS B 505 UNP P0DTC2 TYR 505 VARIANT SEQRES 1 A 594 SER THR ILE GLU GLU GLN ALA LYS THR PHE LEU ASP LYS SEQRES 2 A 594 PHE ASN HIS GLU ALA GLU ASP LEU PHE TYR GLN SER SER SEQRES 3 A 594 LEU ALA SER TRP ASN TYR ASN THR ASN ILE THR GLU GLU SEQRES 4 A 594 ASN VAL GLN ASN MET ASN ASN ALA GLY ASP LYS TRP SER SEQRES 5 A 594 ALA PHE LEU LYS GLU GLN SER THR LEU ALA GLN MET TYR SEQRES 6 A 594 PRO LEU GLN GLU ILE GLN ASN LEU THR VAL LYS LEU GLN SEQRES 7 A 594 LEU GLN ALA LEU GLN GLN ASN GLY SER SER VAL LEU SER SEQRES 8 A 594 GLU ASP LYS SER LYS ARG LEU ASN THR ILE LEU ASN THR SEQRES 9 A 594 MET SER THR ILE TYR SER THR GLY LYS VAL CYS ASN PRO SEQRES 10 A 594 ASP ASN PRO GLN GLU CYS LEU LEU LEU GLU PRO GLY LEU SEQRES 11 A 594 ASN GLU ILE MET ALA ASN SER LEU ASP TYR ASN GLU ARG SEQRES 12 A 594 LEU TRP ALA TRP GLU SER TRP ARG SER GLU VAL GLY LYS SEQRES 13 A 594 GLN LEU ARG PRO LEU TYR GLU GLU TYR VAL VAL LEU LYS SEQRES 14 A 594 ASN GLU MET ALA ARG ALA ASN HIS TYR GLU ASP TYR GLY SEQRES 15 A 594 ASP TYR TRP ARG GLY ASP TYR GLU VAL ASN GLY VAL ASP SEQRES 16 A 594 GLY TYR ASP TYR SER ARG GLY GLN LEU ILE GLU ASP VAL SEQRES 17 A 594 GLU HIS THR PHE GLU GLU ILE LYS PRO LEU TYR GLU HIS SEQRES 18 A 594 LEU HIS ALA TYR VAL ARG ALA LYS LEU MET ASN ALA TYR SEQRES 19 A 594 PRO SER TYR ILE SER PRO ILE GLY CYS LEU PRO ALA HIS SEQRES 20 A 594 LEU LEU GLY ASP MET TRP GLY ARG PHE TRP THR ASN LEU SEQRES 21 A 594 TYR SER LEU THR VAL PRO PHE GLY GLN LYS PRO ASN ILE SEQRES 22 A 594 ASP VAL THR ASP ALA MET VAL ASP GLN ALA TRP ASP ALA SEQRES 23 A 594 GLN ARG ILE PHE LYS GLU ALA GLU LYS PHE PHE VAL SER SEQRES 24 A 594 VAL GLY LEU PRO ASN MET THR GLN GLY PHE TRP GLU ASN SEQRES 25 A 594 SER MET LEU THR ASP PRO GLY ASN VAL GLN LYS ALA VAL SEQRES 26 A 594 CYS HIS PRO THR ALA TRP ASP LEU GLY LYS GLY ASP PHE SEQRES 27 A 594 ARG ILE LEU MET CYS THR LYS VAL THR MET ASP ASP PHE SEQRES 28 A 594 LEU THR ALA HIS HIS GLU MET GLY HIS ILE GLN TYR ASP SEQRES 29 A 594 MET ALA TYR ALA ALA GLN PRO PHE LEU LEU ARG ASN GLY SEQRES 30 A 594 ALA ASN GLU GLY PHE HIS GLU ALA VAL GLY GLU ILE MET SEQRES 31 A 594 SER LEU SER ALA ALA THR PRO LYS HIS LEU LYS SER ILE SEQRES 32 A 594 GLY LEU LEU SER PRO ASP PHE GLN GLU ASP ASN GLU THR SEQRES 33 A 594 GLU ILE ASN PHE LEU LEU LYS GLN ALA LEU THR ILE VAL SEQRES 34 A 594 GLY THR LEU PRO PHE THR TYR MET LEU GLU LYS TRP ARG SEQRES 35 A 594 TRP MET VAL PHE LYS GLY GLU ILE PRO LYS ASP GLN TRP SEQRES 36 A 594 MET LYS LYS TRP TRP GLU MET LYS ARG GLU ILE VAL GLY SEQRES 37 A 594 VAL VAL GLU PRO VAL PRO HIS ASP GLU THR TYR CYS ASP SEQRES 38 A 594 PRO ALA SER LEU PHE HIS VAL SER ASN ASP TYR SER PHE SEQRES 39 A 594 ILE ARG TYR TYR THR ARG THR LEU TYR GLN PHE GLN PHE SEQRES 40 A 594 GLN GLU ALA LEU CYS GLN ALA ALA LYS HIS GLU GLY PRO SEQRES 41 A 594 LEU HIS LYS CYS ASP ILE SER ASN SER THR GLU ALA GLY SEQRES 42 A 594 GLN LYS LEU PHE ASN MET LEU ARG LEU GLY LYS SER GLU SEQRES 43 A 594 PRO TRP THR LEU ALA LEU GLU ASN VAL VAL GLY ALA LYS SEQRES 44 A 594 ASN MET ASN VAL ARG PRO LEU LEU ASN TYR PHE GLU PRO SEQRES 45 A 594 LEU PHE THR TRP LEU LYS ASP GLN ASN LYS ASN SER PHE SEQRES 46 A 594 VAL GLY TRP SER THR ASP TRP SER PRO SEQRES 1 B 238 MET PRO LEU LEU LEU LEU LEU PRO LEU LEU TRP ALA GLY SEQRES 2 B 238 ALA LEU ALA MET ALA ALA ARG VAL GLN PRO THR GLU SER SEQRES 3 B 238 ILE VAL ARG PHE PRO ASN ILE THR ASN LEU CYS PRO PHE SEQRES 4 B 238 HIS GLU VAL PHE ASN ALA THR THR PHE ALA SER VAL TYR SEQRES 5 B 238 ALA TRP ASN ARG LYS ARG ILE SER ASN CYS VAL ALA ASP SEQRES 6 B 238 TYR SER VAL ILE TYR ASN PHE ALA PRO PHE PHE ALA PHE SEQRES 7 B 238 LYS CYS TYR GLY VAL SER PRO THR LYS LEU ASN ASP LEU SEQRES 8 B 238 CYS PHE THR ASN VAL TYR ALA ASP SER PHE VAL ILE ARG SEQRES 9 B 238 GLY ASN GLU VAL SER GLN ILE ALA PRO GLY GLN THR GLY SEQRES 10 B 238 ASN ILE ALA ASP TYR ASN TYR LYS LEU PRO ASP ASP PHE SEQRES 11 B 238 THR GLY CYS VAL ILE ALA TRP ASN SER ASN LYS LEU ASP SEQRES 12 B 238 SER LYS PRO SER GLY ASN TYR ASN TYR LEU TYR ARG LEU SEQRES 13 B 238 PHE ARG LYS SER LYS LEU LYS PRO PHE GLU ARG ASP ILE SEQRES 14 B 238 SER THR GLU ILE TYR GLN ALA GLY ASN LYS PRO CYS ASN SEQRES 15 B 238 GLY VAL ALA GLY PRO ASN CYS TYR SER PRO LEU GLN SER SEQRES 16 B 238 TYR GLY PHE ARG PRO THR TYR GLY VAL GLY HIS GLN PRO SEQRES 17 B 238 TYR ARG VAL VAL VAL LEU SER PHE GLU LEU LEU HIS ALA SEQRES 18 B 238 PRO ALA THR VAL CYS GLY PRO LYS LYS SER THR ASN LEU SEQRES 19 B 238 VAL LYS ASN LYS HET NAG A 701 14 HET NAG A 702 14 HET NAG A 703 14 HET NAG A 704 14 HET NAG B 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 5(C8 H15 N O6) HELIX 1 AA1 THR A 20 THR A 52 1 33 HELIX 2 AA2 THR A 55 GLN A 81 1 27 HELIX 3 AA3 ASN A 90 GLN A 101 1 12 HELIX 4 AA4 ASN A 103 LEU A 108 5 6 HELIX 5 AA5 SER A 109 GLY A 130 1 22 HELIX 6 AA6 GLY A 147 ASN A 154 1 8 HELIX 7 AA7 ASP A 157 ALA A 193 1 37 HELIX 8 AA8 ASP A 198 ARG A 204 1 7 HELIX 9 AA9 SER A 218 TYR A 252 1 35 HELIX 10 AB1 HIS A 265 LEU A 267 5 3 HELIX 11 AB2 TRP A 275 THR A 282 5 8 HELIX 12 AB3 VAL A 293 GLN A 300 1 8 HELIX 13 AB4 ALA A 304 GLY A 319 1 16 HELIX 14 AB5 THR A 324 TRP A 328 5 5 HELIX 15 AB6 THR A 365 MET A 383 1 19 HELIX 16 AB7 PRO A 389 ARG A 393 5 5 HELIX 17 AB8 GLY A 399 ALA A 413 1 15 HELIX 18 AB9 THR A 414 GLY A 422 1 9 HELIX 19 AC1 ASP A 431 VAL A 447 1 17 HELIX 20 AC2 GLY A 448 GLY A 466 1 19 HELIX 21 AC3 TRP A 473 LYS A 481 1 9 HELIX 22 AC4 LEU A 503 ASN A 508 1 6 HELIX 23 AC5 ILE A 513 CYS A 530 1 18 HELIX 24 AC6 PRO A 538 CYS A 542 5 5 HELIX 25 AC7 SER A 547 ARG A 559 1 13 HELIX 26 AC8 PRO A 565 LEU A 570 1 6 HELIX 27 AC9 VAL A 581 PHE A 588 1 8 HELIX 28 AD1 PHE A 588 ASN A 599 1 12 HELIX 29 AD2 ASP B 364 PHE B 371 5 8 HELIX 30 AD3 GLY B 502 GLN B 506 5 5 SHEET 1 AA1 2 LEU A 262 PRO A 263 0 SHEET 2 AA1 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA2 2 TRP A 349 ASP A 350 0 SHEET 2 AA2 2 PHE A 356 ARG A 357 -1 O ARG A 357 N TRP A 349 SHEET 1 AA3 4 ARG B 357 ILE B 358 0 SHEET 2 AA3 4 ASN B 394 ILE B 402 -1 O VAL B 395 N ILE B 358 SHEET 3 AA3 4 TYR B 508 GLU B 516 -1 O GLU B 516 N ASN B 394 SHEET 4 AA3 4 GLY B 431 ASN B 437 -1 N ILE B 434 O VAL B 511 SHEET 1 AA4 3 CYS B 361 VAL B 362 0 SHEET 2 AA4 3 VAL B 524 CYS B 525 1 O CYS B 525 N CYS B 361 SHEET 3 AA4 3 CYS B 391 PHE B 392 -1 N PHE B 392 O VAL B 524 SSBOND 1 CYS A 133 CYS A 141 1555 1555 2.03 SSBOND 2 CYS A 344 CYS A 361 1555 1555 2.03 SSBOND 3 CYS A 530 CYS A 542 1555 1555 2.03 SSBOND 4 CYS B 336 CYS B 361 1555 1555 2.03 SSBOND 5 CYS B 391 CYS B 525 1555 1555 2.03 SSBOND 6 CYS B 480 CYS B 488 1555 1555 2.03 LINK ND2 ASN A 53 C1 NAG A 704 1555 1555 1.44 LINK ND2 ASN A 90 C1 NAG A 702 1555 1555 1.44 LINK ND2 ASN A 322 C1 NAG A 703 1555 1555 1.45 LINK ND2 ASN A 546 C1 NAG A 701 1555 1555 1.44 LINK ND2 ASN B 343 C1 NAG B 601 1555 1555 1.44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000